Cancer Research includes companies working on scientific research aimed at understanding the causes, prevention, diagnosis, treatment, and potential cures for cancer. It includes many disciplines, from biology and genetics, to clinical trials and drug development, with the ultimate goal of improving cancer care and outcomes. Cancer research companies are developing life-saving treatments and diagnostics for a growing market in high demand. These companies constantly innovate, have a global reach, and form important strategic partnerships, which makes them appealing to investors looking for profits and supporting health progress.
Market Snapshot
The Dow Jones Industrial Average rose 484.18 points, or 1.20%, to 40,829.59, the S&P 500 gained 62.63 points, or 1.16%, to 5,471.05 and the...
Gapping up
$Boeing (BA.US)$ shares rose by 4.1% in premarket US trading on Monday after the company tentatively agreed to a 25% pay increase for its biggest union, possibly averting a damaging strike.
Crypto-related stocks such as digital coin exchange $Coinbase (COIN.US)$ and crypto miners $CleanSpark (CLSK.US)$ and $Marathon Digital (MARA.US)$ advanced prior to the opening bell, buoyed by Bitcoin's gain, which ex...
This thing is going to move next week. if there is a pop, better get out while you still can. I will say told you so when it's at 630. Ha.....What that's not going to happen? I guess the meaning of overvalued doesn't exist in this generation. even at half price, this is still overvalued. The only way this thing is worth 1T is if LLY discovered a longevity pill.
$Pfizer (PFE.US)$
$SPDR S&P 500 ETF (SPY.US)$
Gapping up
$Autodesk (ADSK.US)$ Shares rose by 0.8% following the software group's impressive second-quarter results, which were predominantly above consensus forecasts. The company's recent outlook upgrade also suggests strong business momentum.
$Tesla (TSLA.US)$ Shares increased by 1.2% as the electric vehicle manufacturer reported its best sales month of the year in China for August, driven by strong demand in s...
The share price finally stays above 29 today. Hope to see it going to 30 and above next week✌️
$Intel (INTC.US)$ shares rose 9.49% Friday to close at $22.04. Its options trading volume was 1.18 million. Call contracts account for 71.8% of the total trading volume. The $22 calls expiring Aug. 30 were traded most actively.
Intel experienced a notable surge, climbing 9.9% to reach an intraday high of $22.12, following a report by Bloomberg News. The report, which cited "un...
Lucky I didn’t buy SMCI. I feel very blessed to invest in PFE😅
buy
some
for more
No comment yet